Silo Pharma (SILO) Gross Margin (2019 - 2026)
Silo Pharma (SILO) posted Gross Margin of 14.77% for Q1 2026, little changed sequentially from 14.77% in Q4 2025, and down 10667.0% YoY from N/an in Q1 2025.
Silo Pharma (SILO) Gross Margin (2019 - 2026) Analysis & Trends
Silo Pharma has reported Gross Margin for 8 years, with the latest figure at 14.77% in Q1 2026.
- Quarterly Gross Margin fell 10667.0% year-over-year to 14.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.9% (down 8000.0% YoY) and the FY2025 annual result came in at 38.57%, down 5334.0% from the prior year.
- Gross Margin was little changed at 14.77% in Q1 2026 per SILO's latest filing, from 14.77% in the prior quarter.
- Over five years, Gross Margin peaked at 91.91% in Q2 2022 and troughed at 14.77% in Q4 2025.
- A 5-year average of 71.9% and a median of 91.9% in 2022 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2025: Gross Margin soared 6757 bps in 2022, then tumbled 10667 bps in 2025.
- Over 5 years, Gross Margin stood at 91.9% in 2022, then changed by 0 bps to 91.9% in 2023, then changed by 0 bps to 91.9% in 2024, then plunged by 116 bps to 14.77% in 2025, then increased by 0 bps to 14.77% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 14.77%, 14.77%, and 14.77% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Silo Pharma | 2.93 Mn | 2.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.77% |
| Dec 31, 2025 | -14.77% |
| Sep 30, 2025 | -14.77% |
| Jun 30, 2025 | 91.91% |
| Mar 31, 2025 | 91.90% |
| Dec 31, 2024 | 91.90% |
| Sep 30, 2024 | 91.91% |
| Jun 30, 2024 | 91.91% |
| Mar 31, 2024 | 91.90% |
| Dec 31, 2023 | 91.90% |
| Sep 30, 2023 | 91.91% |
| Jun 30, 2023 | 91.91% |
| Mar 31, 2023 | 91.90% |
| Dec 31, 2022 | 91.90% |
| Sep 30, 2022 | 91.91% |
| Jun 30, 2022 | 91.91% |
| Jun 30, 2021 | 24.33% |
| Mar 31, 2021 | -2.27% |
| Dec 31, 2020 | -584.92% |
| Sep 30, 2020 | -80.84% |